Catalog Number 03L77-01 |
Device Problem
High Test Results (2457)
|
Patient Problem
No Known Impact Or Consequence To Patient (2692)
|
Event Type
malfunction
|
Manufacturer Narrative
|
An evaluation is in process.A follow-up report will be submitted when the evaluation is complete.
|
|
Event Description
|
The customer observed false elevated magnesium patient results generated using the architect c16000 analyzer.The following data was provided.The customer uses normal range 0.7 to 1.0 mmol/l.(b)(4) initial 3.9, repeat 0.65.No impact to patient management was reported.
|
|
Manufacturer Narrative
|
Investigation of the customer issue included a review of the complaint text, a search for similar complaints, a review of labeling, and instrument service.No returns were made available from the customer site for this evaluation.No adverse trend was identified for the customer issue.Labeling was reviewed and found to be adequate.The issue was resolved through standard troubleshooting procedures.Based on all available information and abbott diagnostics complaint investigation, the analyzer performed as intended and no product deficiency was identified.
|
|
Manufacturer Narrative
|
(b)(4).Submission 1628664-2016-00227 documents the incident and subsequent investigation summary for the architect c16000, list 03l77-01, serial (b)(4).After completion of our investigation it was determined the analyzer that generated the incorrect result was the architect c8000, list 01g06-01, serial (b)(4) and a new submission 1628664-2016-00284 was submitted for the architect c8000 due to our system requirements.Therefore, this second follow-up to 1628664-2016-00227 is being submitted referring to 1628664-2016-00284 and clarifying that mdr 1628664-2016-00285 follow-up was incorrectly submitted.Note: this follow up is in response to an fda inquiry regarding mdr 1628664-2016-00285, indicating a correction was needed and 1628664-2016-00285 would be deleted from the system.
|
|
Search Alerts/Recalls
|